In This Story NVO -2.02% ASND +0.30% LLY -1.55% VKTX -13.41% Novo Nordisk ( NVO -2.02% ) , the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with Denmark-based Ascendis Pharma ( ASND +0.30% ) to leverage the latter’s advanced drug delivery technology. Suggested Reading A Michigan villa, a Georgia mansion, and a Pennsylvania ranch: this week’s swing state luxury real estate roundup Levi's, Nike, Patagonia: These 7 major brands could get more

Tag-uri: Real Estate